Eye: the company is one of China's largest ophthalmic medical institutions, has built more than 40 professional eye hospitals across the country, mainly to carry out myopia treatment, cataract surgery, corneal disease, medical optometry, ocular trauma and other diagnostic and treatment projects, set up a "myopic surgery area", "cataract diagnosis and treatment area", "medical optometry center" and other professional and technical areas. Among them, the "Myopia Surgery Zone" is the largest in China, with the world's top sets of femtosecond laser surgery systems, and all equipped with the most advanced wavefront phase contrast inspection system and various high-end scientific research equipment.
Ogawa: The company's controlling subsidiary, Air Purification Company, together with Guangzhou Institute of Respiratory Diseases, Guangzhou Exhalation Research Institute Pharmaceutical Company and Hong Kong Henry Fok Zhenyu Foundation and other 12 units held a signing ceremony for the project of "Respiratory Infectious Diseases Prevention, Control, Diagnosis and Treatment of New Technology and Product Research and Development and Industrialization". The target products of the project are diagnostic reagents, medical devices, drugs, vaccines, infection control and other technology and product development and industrialization, the expected goal is to spend five years to build the prevention and control of respiratory infectious diseases, diagnosis and treatment of innovative technologies, as well as product development capabilities with international competitiveness of an innovation and entrepreneurship team, a professional support platform for the relevant industries, a national engineering technology center, a respiratory system, drugs and devices for infectious diseases. Infectious disease control drugs and devices products of the biomedical industry group, to complete the construction of the respiratory infectious diseases in the field of international influence of the collaborative innovation center.
Opkang vision: ophthalmic medical equipment leader, mainland China's only R & D and production of corneal reshaping lenses product registration certificate, but also the first ophthalmology R & D and production of listed companies; products for the rigid corneal contact lenses and lens care products, dream DAVID keratoconus as the core product; hold 51% stake in Aotec, the subject of the main business of medical equipment, eyeglasses and accessories, etc.; 17 years Medical equipment revenue of 312 million, accounting for 100%.
Synthesized above, is some, in the A stock market, very much attention, and medical equipment related to quality stocks, I hope this article can give you help!